Houston Methodist DeBakey Heart and Vascular Center


 

Update on Inflammation & Atherosclerosis Treatment: Should All Atherosclerosis Patients Receive Aggressive Lipid-Lowering and Inflammation Inhibiting Therapy? Why Not Combine Anti-Inflammatory Therapy with PCSK9 Inhibition?

1,523 views
July 14, 2020
Comments 0
Login to view comments. Click here to Login